Chemours

CC

Market cap $1.92B

Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.

CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results.

The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies LLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Vincent Andrews - Morgan Stanley, Research Division Roger Spitz - BofA Securities, Research Division Aaron Rosenthal - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. My name is Gigi, and I'll be your conference operator today.

Earnings were light, driven by slowing sales of titanium dioxide, a key component of white paint.

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Chemours (CC) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.4 per share a year ago.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2025 Results.

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.